05/23/22 8:10 AMNYSE : EW conferencesEDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCEEdwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernstein 38th Annual Strategic Decisions Conference on Thursday, June 2, 2022.Michael A. Mussallem, chairman and chief executive officer, is scheduled toRHEA-AIneutral
05/16/22 9:15 AMNYSE : EW EDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022Edwards Lifesciences Corporation (NYSE: EW) announced key events for the company during EuroPCR 2022, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). The event takes place May 17 to 20 at the Palais desRHEA-AIneutral
04/26/22 4:15 PMNYSE : EW EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTSEdwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2022.First Quarter Highlights and OutlookQ1 sales grew 10 percent to $1.34 billion; underlying 1 13 percent Q1 TAVR sales grew 11 percent; underlyingRHEA-AIpositive
04/19/22 7:05 AMNYSE : EW conferencesearningsEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2022 after the market closes on Tuesday, April 26, 2022, and will host a conference call at 5:00 p.m. ET that day to discuss those results.ToRHEA-AIneutral
03/31/22 9:15 AMNYSE : EW fda approvalEDWARDS MITRIS RESILIA VALVE RECEIVES FDA APPROVAL FOR MITRAL REPLACEMENT SURGERIESEdwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position.The MITRIS RESILIARHEA-AIvery positive
01/26/22 4:15 PMNYSE : EW EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTSEdwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2021.Fourth Quarter Highlights and Outlook2021 sales grew 19 percent, or 18 percent on an underlying 1 basis Q4 sales grew 12 percent to $1.33RHEA-AIvery positive
01/19/22 7:05 AMNYSE : EW conferencesearningsEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 26, 2022Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2021 after the market closes on Wednesday, January 26, 2022, and will host a conference call at 5:00 p.m. ET that day to discuss thoseRHEA-AIneutral
01/05/22 8:10 AMNYSE : EW conferencesEDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEEdwards Lifesciences Corporation (NYSE: EW) today announced it will participate at the J.P. Morgan Healthcare Conference on Monday, January 10, 2022.Michael A. Mussallem, chairman and chief executive officer, is scheduled to present virtually at 11:15RHEA-AIneutral
12/20/21 9:05 AMNYSE : EW fda approvalEDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH ALTERRA PRESTENT FOR TRANSCATHETER PULMONIC VALVE REPLACEMENTEdwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent (SAPIEN 3 with Alterra) for patients withRHEA-AIpositive
12/08/21 9:05 AMNYSE : EW Edwards Lifesciences Outlines Growth Strategy at Annual Investor ConferenceEdwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance 1 today during its annual investor conference.Highlights of today'sRHEA-AIneutral